What is Avicenna Biosciences worth?
$5.1Mlast known valuation
Avicenna Biosciences last raised $6.0M in its Debt (Jul 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Avicenna Biosciences
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Debt | $6.0M | ▮ | ▮ |
| Nov 2023 | Debt | $6.0M | ▮ | ▮ |
| Apr 2022 | Seed Round | $3.0M | ▮ | ▮ |
| Aug 2020 | Seed Round | $2.5M | ▮ | ▮ |
How Avicenna Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Avicenna Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Avicenna Biosciences worth?
- Avicenna Biosciences's last known valuation is $5.1M.
- How much has Avicenna Biosciences raised?
- Avicenna Biosciences has raised $20.5M in total funding across 4 recorded rounds.
- When did Avicenna Biosciences last raise?
- Avicenna Biosciences last raised in Jul 2024 (Debt), raising $6.0M.